The Genetics of Alzheimer Disease
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Family history is the second strongest risk factor for Alzheimer disease (AD) following advanced age.Twin and family studies indicate that genetic factors are estimated to play a role in at least 80% of AD cases.The inheritance of AD exhibits a dichotomous pattern.On one hand, rare mutations in APP, PSEN1, and PSEN2 virtually guarantee early-onset (,60 years) familial AD, which represents 5% of AD.On the other hand, common gene polymorphisms, such as the 14 and 12 variants of the APOE gene, can influence susceptibility for 50% of the common late-onset AD.These four genes account for 30% -50% of the inheritability of AD.Genome-wide association studies have recently led to the identification of 11 additional AD candidate genes.This paper reviews the past, present, and future attempts to elucidate the complex and heterogeneous genetic underpinnings of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“To date, 228 PSEN1 mutations have been identified causing ADAD (49, 303, 304, 440, 566, 580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“CLU gene encodes clusterin or APOJ that besides its functions in lipid transport, membrane recycling, cell adhesion, and apoptosis (90, 444, 600, 677) affects transvascular A 𝛃 clearance by promoting A 𝛃 42 efflux across the BBB (580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PSEN1 mutations lead to faster soluble-to-fibrillar conversion of A 𝛃 42 promoting amyloid deposition in the brain (303, 566, 580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Autosomal-dominant AD (ADAD) is an inherited form of AD caused by mutations in amyloid precursor protein ( APP ) and presenilin-1 and 2 ( PSEN1; PSEN2 ) genes (49, 177, 303, 304, 580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
The cited source says what the claim attributes to it.
In the citing paper
“APOE4 is the major genetic risk factor for sporadic, late-onset AD (199, 368, 580, 612).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 3×
“Goate et al. (1991), then resequenced the same two APP exons to reveal the first EO-FAD mutation (London mutation; V717I) in APP.”
BackgroundThe precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · cited 1×
“In 1987, we as well as others isolated the amyloid b (A4) protein precursor (APP; Goldgaber et al. 1987; Kang et al. 1987; Tanzi et al. 1987a, 1988) and mapped it to chromosome 21.”
BackgroundCloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 3×
“1987b); they were ultimately demonstrated to carry PSEN1 mutations (Sherrington et al. 1995).”
BackgroundSelf-citationHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · cited 14×
“Genetic association studies remain the most common method for identifying novel LOAD genes and are most often employed in the form of large-scale GWASs that screen the entire human genome for novel disease loci.”
InfluentialScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · cited 3×
“Whether EO-FAD mutations appear in APP near the g-secretase cleavage site or in the presenilins, the vast majority of them serve to increase the ratio of Ab42:Ab40. g-Secretase modulators are aimed at reversing this ratio and represent very promising compounds for treating and preventing AD based on what has been garn…”
BackgroundSelf-citationCandidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · cited 1×
“Shortly thereafter, we first reported a homolog of PSEN1 called presenilin (PSEN2; Levy-Lahad et al. 1995) on chromosome 1 and showed that it harbors the N141I mutation in Volga-German EO-FAD families.”
BackgroundSelf-citationGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Research works printed but not linked: 2
- Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zis- mann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huen- telman MJ, et al. 2007. Papassotiropoulos A, Stephan DA. GAB2 alleles modify Alzheimer's risk in APOE 14 car- riers. Neuron 54: 713 -720.
- Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipopro- tein E: High-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 90: 1977-1981.
Cited by
Items 501–600 of 804
Novel Molecular Targets and Mechanisms for Neuroprotective Modulation in Neurodegenerative Disorders
Irannejad, H., Azari, A., Goodarzi, A., Jafarkhani, B., Eghbali, M., Karimi, Z., & Balef, S. S. H. (2022) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524922666220616092132 · Cited by 8
Phytochemical based Modulation of Endoplasmic Reticulum Stress in Alzheimer's Disease
Dsouza, V. L., Shivakumar, A. B., Kulal, N., Gangadharan, G., Kumar, D., & Kabekkodu, S. P. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220624155357 · Cited by 8
Evin, G. M., & Barakat, A. (2014) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s41056 · Cited by 12
Cannabinoids as multifaceted compounds
Persia, D., Mangiavacchi, F., Marcotullio, M. C., & Rosati, O. (2023) · Phytochemistry · doi:10.1016/j.phytochem.2023.113718 · Cited by 7
Alzheimer’s disease and clinical trials
Paul, D., Agrawal, R., & Singh, S. (2024) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2023-0264 · Cited by 9
Filomena, E., Picardi, E., Tullo, A., Pesole, G., & D’Erchia, A. M. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1437278 · Cited by 7
The genetic landscape of early and late-onset Alzheimer’s disease: A review
Saragea, P. D. (2024) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2024-0030 · Cited by 7
Gómez‐Ramos, A., Picher, Á. J., García, E., Garrido, P., Hernández, F., Soriano, E., & Ávila, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161053 · Cited by 7
Khoba, K., Kumar, S., Chatterjee, S., & Purty, R. S. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-03937-1 · Cited by 9
Jin, C., Zhang, F., Liu, X., Wang, B., Cheng, Z., Zhao, X., Zhu, J., Wang, D., Wang, Y., Dong, A., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s85370 · Cited by 7
Twenty Years of Presenilins—Important Proteins in Health and Disease
Walter, J. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00163 · Cited by 9
DNA Methylation in Neuronal Development and Disease
Bruggeman, E. C., & Yao, B. (2019) · RNA technologies · doi:10.1007/978-3-030-14792-1_5 · Cited by 8
Hark, T. J., & Savas, J. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15298 · Cited by 9
Abanmy, N. O., Alsabhan, J. F., Gard, P., & Scutt, G. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.10.007 · Cited by 8
Mani, R., Sulthana, A. S., Muthusamy, G., & Elangovan, N. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2317 · Cited by 7
Zhai, T., Krass, E., Zhang, F., & Huang, Z. J. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2023.1188430 · Cited by 7
Magrì, A. L., Natale, G. D., & Rizzarelli, E. (2017) · Inorganica Chimica Acta · doi:10.1016/j.ica.2017.10.032 · Cited by 7
Pollock, T. B., Mack, J. M., Day, R. J., Isho, N. F., Brown, R. J., Oxford, A. E., Morrison, B. E., Hayden, E. J., & Rohn, T. T. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5123565 · Cited by 7
APOE genotype-dependent differences in human astrocytic energy metabolism
Budny, V., Bodenmann, C., Zürcher, K. J., Krüger, M., de Leeuw, S. M., Weber, R. Z., Rust, R., Ravotto, L., Ruminot, I., Barros, L. F., et al. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1603657 · Cited by 6
“Among those, the ε 4 allele of the apolipoprotein E ( APOE4 ) represents the strongest genetic risk factor (Tanzi, 2012).”
Neupane, S., & Hortobágyi, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411811 · Cited by 6
Brioschi, S., Belk, J. A., Storck, S. E., Wu, Y., Wang, Z., Feng, Z., van Olst, L., Emery, J. L., Sudan, R., Wu, J., et al. (2026) · Cell · doi:10.1016/j.cell.2026.07.043 · Cited by 9
Jiang, F., Wang, N., & Meng, Q. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251360321 · Cited by 6
ORP150‐CHIP chaperone antagonism control BACE1‐mediated amyloid processing
Chanana, N., & Pati, U. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26630 · Cited by 6
Effects of noninherited ancestral genotypes on offspring phenotypes†
Cullen, S. M., Hassan, N. A., & Smith-Raska, M. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab120 · Cited by 6
Butyrylcholinesterase signal sequence self-aggregates and enhances amyloid fibril formation in vitro
Jasiecki, J., Targońska, M., Janaszak‐Jasiecka, A., Kalinowski, L., Waleron, K., & Wasąg, B. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110783 · Cited by 8
Khalifa, J., Bourgault, S., & Gaudreault, R. (2023) · Current Alzheimer Research · doi:10.2174/0115672050277001231213073043 · Cited by 7
Han, S., Cho, S.-A., Choi, W., Eilbeck, K. L., Coon, H. H., Nho, K. T., & Lee, Y. (2025) · BMC Genomics · doi:10.1186/s12864-025-11362-x · Cited by 7
Stanciu, G. D., Ababei, D. C., Rusu, R.-N., Bild, V., & Tamba, B.-I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061270 · Cited by 7
Vasco, V. R. L. (2023) · OBM Geriatrics · doi:10.21926/obm.geriatr.2302234 · Cited by 6
Stępnik, J., Kędra, A., & Czaprowski, D. (2023) · Medical Science Monitor · doi:10.12659/msm.941167 · Cited by 6
Aging, Dementia, and Alzheimer Disease
Sontheimer, H. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800244-5.00004-5 · Cited by 8
Stem Cell Technology for (Epi)genetic Brain Disorders
Riemens, R. J. M., Soares, E. S., Esteller, M., & Delgado‐Morales, R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_23 · Cited by 8
Murakami, M., Ikeda, Y., Nakagawa, Y., Tsuji, A., Kitagishi, Y., & Matsuda, S. (2020) · Biomedical Reports · doi:10.3892/br.2020.1310 · Cited by 6
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00004-2 · Cited by 6
Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort
Daniel, A. A., Silzer, T. K., Sun, J., Zhou, Z., Hall, C. L., Phillips, N., & Barber, R. C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221031 · Cited by 7
Orban, P., Tam, A., Urchs, S. G. W., Savard, M., Madjar, C., Badhwar, A., Dansereau, C. L., Vogel, J. W., Schmuel, A., Dagher, A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/195164 · Cited by 6
Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease
Rebassa, J. B., Capó, T., Lillo, J., Raïch, I., Reyes‐Resina, I., & Navarro, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105378 · Cited by 5
Tasnády, K. R., Jehoul, R., de Ravé, M. G., Gijbels, M. J., Brône, B., Dewachter, I., Melotte, V., & Boesmans, W. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.15016 · Cited by 6
Severe Chronic Traumatic Encephalopathy in a US Naval Special Warfare Combatant Crewman
Priemer, D. S., Rhodes, C. H., Stewart, G. W., Villar, J., Dalgard, C. L., & Perl, D. P. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.17686 · Cited by 5
Exploring Alzheimer’s diseases with focus on diagnostic strategies targeting amyloid beta 42 (Aβ42)
Chauhan, A., Devi, R., Singh, S., Bhutani, K., Prasad, S., Singh, A., Bhaskar, N., Kumar, S., Saini, A. K., & Thakur, R. (2025) · Discover Neuroscience · doi:10.1186/s13064-025-00217-6 · Cited by 6
The complex of gut microbial metabolites and sex hormones in Alzheimer’s disease
Bahar, A., Khazaei, M., & Tahmasebi, H. (2026) · Seminars in Immunopathology · doi:10.1007/s00281-026-01076-x · Cited by 5
Al-Abdulraheem, Z., & Durdağı, S. (2023) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2023.108575 · Cited by 5
Esteban-Martos, Á., Brokate-Llanos, A. M., Real, L. M., Melgar‐Locatelli, S., de Rojas, I., Castro‐Zavala, A., Bravo, M. J., Mañas‐Padilla, M. C., García‐González, P., Ruiz‐Galdón, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512079 · Cited by 5
The Life Course Approach to Cognitive Aging and Dementia
Chey, J., & Kwak, S. (2023) · Cambridge University Press eBooks · doi:10.1017/9781108974325.009 · Cited by 5
Zhang, B., Xu, M., Wu, Q. H., Ye, S., Zhang, Y., Li, Z., & Initiative, A. D. N. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1328301 · Cited by 5
Vieira, R. N., Magalhães, J. D., Sant’Anna, J., Moriguti, M. M., de Miranda, D. M., Marco, L. D., de Moraes, E. N., Romano‐Silva, M. A., Bicalho, M. A. C., de Paula, J. J., et al. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215000514 · Cited by 5
Prospects and Challenges for Alzheimer Therapeutics
Wolfe, M. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00023-x · Cited by 5
Yin, J., Feng, W. Q., Yuan, H., Yuan, J., Wu, Y., Liu, X., Jin, C., & Cheng, Z. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s186705 · Cited by 5
Porphyromonas Gingivalis in the Pathogenesis of Alzheimer’s Disease and Its Therapeutic Target
Seymour, T., & Zhang, J. (2021) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2021.00030 · Cited by 6
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art
(2017) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681084930117020011 · Cited by 6
Comorbidity of Dementia: A Cross-Sectional Study of PUMCH Dementia Cohort
Shang, L., Dong, L., Huang, X., Chu, S., Jin, W., Bao, J., Wang, T., Mao, C., & Gao, J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231025 · Cited by 7
Lipids and Lipoproteins in Alzheimer’s Disease
Stukas, S. K., Kulić, I., Zareyan, S., & Wellington, C. L. (2015) · InTech eBooks · doi:10.5772/59808 · Cited by 6
Watanabe, Y., Shibata, K., & Maekawa, M. (2014) · Epigenetics · doi:10.4161/15592294.2014.967585 · Cited by 5
Designed Helical Peptides as Functional Probes for γ-Secretase
Philip, A. T., Devkota, S., Malvankar, S. R., Bhattarai, S., Meneely, K. M., Williams, T. D., & Wolfe, M. S. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00639 · Cited by 6
Direct conversion of fibroblast into neurons for Alzheimer's disease research: a systematic review
Sattarov, R., Toresson, H., Orbjörn, C., & Mattsson-Carlgren, N. (2023) · Journal of Alzheimer’s Disease · doi:10.3233/jad-230119 · Cited by 4
“%) have sporadic AD (SAD) which typically occurs past the age of 65, often referred to as late-onset AD (LOAD) [8].”
BackgroundUnderstanding the Bidirectional Relationship between Alzheimer's and Depression
Pannu, A. S., & Goyal, R. K. (2024) · Current Psychiatry Research and Reviews · doi:10.2174/0126660822303361240903075653 · Cited by 5
Rajendrakumar, A. L., Arbeev, K. G., Bagley, O., Duan, M., Yashin, A. I., Ukraintseva, S. V., & Initiative, A. D. N. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316808 · Cited by 4
Sarma, M., & Chatterjee, S. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07237-1 · Cited by 4
Barron, A. E., Lin, J. S., Ryder, M. I., & Bergman, P. N. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70060 · Cited by 4
Suswidiantoro, V., Tang, K. S., Rahman, K., Puteri, M. U., Wahyuni, T., Ariestanti, D. M., James, R. J., Yan, C. C., Kato, M., & Saputri, F. C. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101248 · Cited by 5
Janus, C., Hernandez, C., deLelys, V., Roder, H. M., & Welzl, H. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3661-8_18 · Cited by 4
Khaled, M., Al-Jamal, H., Tajer, L., & El-Mir, R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231432 · Cited by 4
Kreutzer, E., Short, J. L., & Nicolazzo, J. A. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03731-0 · Cited by 4
Association of GLOD4 with Alzheimer’s Disease in Humans and Mice
Utyro, O., Włoczkowska, O., & Jakubowski, H. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240512 · Cited by 4
Can cognitive reserve offset APOE-related Alzheimer’s risk? A systematic review
da Silva, S. P., Lampraki, C., Rêgo, T. S., Ghisletta, P., Kliegel, M., Maurer, J., Studer, M., Gouveia, É. R., Nascimento, M. D. M., & Ihle, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102809 · Cited by 5
Yang, E., Al-Ghraiybah, N. F., Alkhalifa, A. E., Woodie, L. N., Swinford, S. P., King, J., Greene, M. W., & Kaddoumi, A. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100357 · Cited by 5
Wei, Y., Zhang, M., Hu, J. T., Zhou, Y., Xue, M., Yin, J., Liu, Y., Feng, H., Zhou, L., Li, Z., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac043 · Cited by 7
How to Prevent and/or Revert Alzheimer’s Disease Continuum During Preclinical Phases
Ávila‐Villanueva, M., Dolado, A. M., & Fernández‐Blázquez, M. A. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr220100 · Cited by 4
Laadraoui, J., Kabdy, H., Oufquir, S., Aitlarradia, M., Agouram, F., Aitbaba, A., Oubella, K., & El‐Mansoury, B. (2025) · IGI Global eBooks · doi:10.4018/979-8-3693-9112-9.ch005 · Cited by 4
Development of a Reporter System for In Vivo Monitoring of γ-Secretase Activity in Drosophila
Hong, Y. G., Roh, S., Paik, D., & Jeong, S. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.2294 · Cited by 4
Sys, S., Fournier, D., Horenko, I., Endres, K., & Gerber, S. (2018) · Genomics and Computational Biology · doi:10.18547/gcb.2018.vol4.iss2.e100045 · Cited by 4
Contributing Factors of Neurodegeneration in Alzheimer’s Disease
Tailor, B. A., Pilozzi, A. R., & Huang, X. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch5 · Cited by 6
Beşli, N., & Yenmiş, G. (2020) · Acta chimica slovenica · doi:10.17344/acsi.2020.6175 · Cited by 4
Liu, S., Zhang, Z., Li, L., Yao, L., Ma, Z. S., & Li, J. (2022) · The FASEB Journal · doi:10.1096/fj.202201396r · Cited by 6
Adapting simultaneous analysis phylogenomic techniques to study complex disease gene relationships
Romano, J. D., Tharp, W. G., & Sarkar, I. N. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.01.002 · Cited by 4
Lysosomal enzyme tripeptidyl peptidase 1 plays a role in degradation of beta amyloid fibrilsPreprint
Cruz, D. L., El-Banna, M., Majumdar, A., Sleat, D. E., Muldowney, M. T., Lobel, P., & Maxfield, F. (2019) · bioRxiv · doi:10.1101/639682 · Cited by 3
Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?
Correia, S. C., Perry, G. L., & Moreira, P. I. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240787 · Cited by 3
Mishra, A. K., Srivastava, A., Raj, V., Saini, V., Khan, G., Singh, H., Mishra, A., & Paliwal, S. (2024) · Current Alzheimer Research · doi:10.2174/0115672050361294241211071813 · Cited by 4
Özkaya, A. L., Gürbüzer, N., Mercantepe, T., & Mercantepe, F. (2025) · Biomolecules · doi:10.3390/biom15060795 · Cited by 3
Raikes, A. C., Bhattrai, A., Wang, T., Wiegand, J. L., & Brinton, R. D. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1843319 · Cited by 3
Dementia: Genes, Environments, Interactions
Gatz, M., Jang, J. Y., Karlsson, I., & Pedersen, N. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7447-0_7 · Cited by 3
Utility of animal models of Alzheimer's disease in food bioactive research
Lange, K. W. (2021) · Journal of Food Bioactives · doi:10.31665/jfb.2020.13255 · Cited by 3
Acetylcholine - Recent Advances and New Perspectives
Heinbockel, T. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106304 · Cited by 5
Revealing the binding mechanism of BACE1 inhibitors through molecular dynamics simulations
Zhang, Y., Miao, D., Liu, S., & Hao, X. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2319676 · Cited by 6
Cannabinoid CB1 Receptor Activation Mitigates N-Methyl- d -aspartate Receptor-Mediated Neurotoxicity
Navarro, G., Raïch, I., Rebassa, J. B., Lillo, J., Pérez-Olives, C., Capó, T., Cubeles-Juberias, E., Saura, C. A., Cordomí, A., Sotelo, E., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00230 · Cited by 3
Bin, Y., Zhu, Q., Li, M., & Xia, J. (2019) · IEEE Access · doi:10.1109/access.2019.2935515 · Cited by 3
Functional measures and AD biomarkers among Hispanic and White non‐Hispanic older adults
Rodriguez, M. J., Mendoza, L., Garcia, P., Duarte, A., Padrón, D., Marsiske, M., Fiala, J. A., Gonzalez, J., & Duara, R. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12632 · Cited by 3
Tian, Y., Felsky, D., Gronsbell, J. L., & Park, J. Y. (2025) · Imaging Neuroscience · doi:10.1162/imag_a_00580 · Cited by 4
Vassar, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00003-4 · Cited by 4
α7-Nicotinic Acetylcholine Receptors and β-Amyloid Peptides in Alzheimer’s Disease
Lorke, D. E., Petroianu, G. A., & Öz, M. (2016) · Neuromethods · doi:10.1007/978-1-4939-3768-4_10 · Cited by 6
Fate Through Fat: Neutral Lipids as Regulators of Neural Stem Cells
Hamilton, L. K., & Fernandes, K. J. L. (2017) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-49343-5_5 · Cited by 4
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art
Pederzoli, F., Galliani, M., Forni, F., Vandelli, M. A., Belletti, D., Tosi, G., & Ruozi, B. (2017) · IRIS UNIMORE (University of Modena and Reggio Emilia) · doi:10.2174/97816810849301170201 · Cited by 3
The Ethics of Biomarker-Based Preclinical Diagnosis of Alzheimer’s Disease
Kurz, A., & Lautenschlager, N. T. (2018) · Neuromethods · doi:10.1007/978-1-4939-7674-4_17 · Cited by 3
Prion-Like Propagation in Neurodegenerative Diseases
Peelaerts, W., Baekelandt, V., & Brundin, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00008-0 · Cited by 4
Qian, Y., Tang, X., Shen, R., Lu, Y., Ding, J., Qian, X., & Zhang, C. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241300947 · Cited by 2
Li, M., Wu, X., Jiang, L., Liu, M., Yanju, G., Li, X., Fan, T., Fan, Y., Wang, J., Wang, S., et al. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12527 · Cited by 2
Soelter, T. M., Howton, T. C., Wilk, E. J., Whitlock, J. H., Clark, A. D., Birnbaum, A., Patterson, D. C., Cortés, C. J., & Lasseigne, B. N. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70006 · Cited by 2
PolyGR-containing aggregates link with pathology and clinical features of Alzheimer’s disease
Phuong, H. T., Tomas, R. F., Akmese, C., Mijares, A. M. P., Gerstin, I. M., Guo, S., Bell, L. R., Ellwood, R., Yegorova, S., Ng, S. K., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02954-8 · Cited by 2
Kritikos, M., Rama, T., Zubair, V., Huang, C., Christodoulou, C., Chen, A. P. F., Kotov, R., Mann, F. D., & Initiative, O. B. O. T. A. D. N. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2030024 · Cited by 2
Nagarajan, V. D., Libowitz, C. L., Ackley, B. D., & Wolfe, M. S. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107267 · Cited by 2
Metadata
- Authors
- Tanzi, R. E.
- Affiliations
- Harvard University (US)
- Corresponding author
- Tanzi, R. E.
- ORCID
- Tanzi, R. E.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-07-25
- Volume
- 2
- Issue
- 10
- Pages
- a006296-a006296
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W4233829850
- Cited by
- 727
- References
- 55
- Citations by year
- 2026: 40 · 2025: 55 · 2024: 58 · 2023: 70 · 2022: 54 · 2021: 49 · 2020: 54 · 2019: 40 · 2018: 42 · 2017: 55 · 2016: 60 · 2015: 52 · 2014: 61 · 2013: 32 · 2012: 5
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, genetic susceptibility, familial Alzheimer's disease, APP mutations, presenilin 1, presenilin 2, apolipoprotein E, APOE ε4, late-onset Alzheimer's disease, twin and family studies, genome-wide association study, candidate genes, heritability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.